We haven’t talked about Brett Favre in a few weeks, so you might be curious as to what he’s been up to lately.
Oh, and now he’s apparently become a spokesman for a prescription pain cream product that might or might not be FDA-approved.
As the Milwaukee Journal Sentinel explains, the cream is called Rx Pro, and yes, it appears as though Favre is a true believer in the product.
"I can speak volumes on pain and narcotics use," Favre said in a Sirius XM interview about two weeks ago. “[Rx Pro] is a safe way to treat some of your ailments. It even works with cramps, stomach pain ... It's just endless what will happen with this product and this company."
Favre said he put the cream on his ankles, and suddenly the pain dissipated. Now he also doesn’t have to deal with cramping calves, something that bothered him during his career. Favre is an investor in the product, and it sounds like the company plans to use Favre in its marketing.
But here’s one potential problem. It might not actually be approved by the FDA.
From the Journal Sentinel:
Byron Barrett, the president of the sports medicine unit of World Health Industries [which makes and manufactures RX Pro], said in an interview and follow-up email that the product was safe. He said he believed it was FDA-approved.
Barrett said the product contained no substances that are banned by the National Football League, though he declined to identify the ingredients.
The cream is available only by prescription, according to Barrett and a customer service representative. The website says Rx Pro fights inflammation, neuropathy and fibromyalgia.
But Erica Jefferson, an FDA spokeswoman, said she could find no evidence that Rx Pro is an FDA-approved product.
So, at this point the product looks a little iffy. When a high-ranking official in the company isn’t sure whether that product is FDA-approved and when he won’t tell you the ingredients, well, maybe it’s worth taking a closer look into what that company actually is trying to sell you.
Hopefully, Favre has done his homework as well.